6533b7defe1ef96bd1276790
RESEARCH PRODUCT
Will the COVID-19 pandemic affect HCV disease burden?
Stephen D. RyderAntonio CraxìAndrea MarcellusiLoreta A. Kondilisubject
2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)Pneumonia ViralTime to treatmentAffect (psychology)Antiviral AgentsArticleTime-to-TreatmentBetacoronavirusPandemicHumansMedicineDisease EradicationPandemicsDisease burdenAntiviral AgentDisease EradicationbiologyHepatologyBetacoronaviruPandemicbusiness.industryCoronavirus InfectionSARS-CoV-2GastroenterologyCOVID-19Hepatitis C Chronicbiology.organism_classificationVirologyCoronavirus InfectionsbusinessBetacoronavirusHuman| year | journal | country | edition | language | 
|---|---|---|---|---|
| 2020-09-01 |